Tag Archives: BTG

Top 10 Medical Stocks To Invest In 2019

CEO of Apollo Endosurgery Inc (NASDAQ:APEN) Todd Newton bought 72,727 shares of APEN on 06/20/2018 at an average price of $5.5 a share. The total cost of this purchase was $399,998.

Apollo Endosurgery Inc is a developer of medical devices in the United States. The company’s major focus area is obesity and gastrointestinal diseases. Apollo Endosurgery Inc has a market cap of $113.820 million; its shares were traded at around $6.50 with and P/S ratio of 1.43. Apollo Endosurgery Inc had annual average EBITDA growth of 44.30% over the past five years.

CEO Recent Trades:

CEO Todd Newton bought 72,727 shares of APEN stock on 06/20/2018 at the average price of $5.5. The price of the stock has increased by 18.18% since.

CFO Recent Trades:

CFO, Treasurer, Secretary Stefanie L. Cavanaugh bought 4,545 shares of APEN stock on 06/20/2018 at the average price of $5.5. The price of the stock has increased by 18.18% since.

Directors and Officers Recent Trades:

Director, 10% Owner Matthew S Crawford bought 363,500 shares of APEN stock on 06/20/2018 at the average price of $5.5. The price of the stock has increased by 18.18% since.

For the complete insider trading history of APEN, click here

Top 10 Medical Stocks To Invest In 2019: Sanofi(SNY)

Advisors’ Opinion:

  • [By Max Byerly]

    COPYRIGHT VIOLATION NOTICE: “Sanofi (SNY) Stock Rating Reaffirmed by Deutsche Bank” was first posted by Ticker Report and is owned by of Ticker Report. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this story can be read at https://www.tickerreport.com/banking-finance/3361890/sanofi-sny-stock-rating-reaffirmed-by-deutsche-bank.html.

  • [By Todd Campbell]

    A population of 741 million people makes Europe a huge market for drugmakers, yet most investors avoid European healthcare stocks in their portfolios. Is that a mistake? It could be, especially when it comes to Sanofi SA (NYSE:SNY), a French biopharma giant that’s trading at a reasonable valuation and offers a market-trouncing dividend yield.

  • [By ]

    If that’s not enough excitement for you, French drug maker Sanofi SA (NYSE:SNY) announced it’s buying Bioverativ (NASDAQ:BIVV) for $11.6 billion. The deal pushed BIVV shares up more than 60% by the closing bell.

  • [By Cory Renauer]

    The ability to pick winners extends beyond MS. In 2017, Biogen spun off its rare bleeding disorder segment into a separate company that Sanofi (NYSE:SNY) acquired for a whopping $11.6 billion in cash earlier this year. Biogen also reported a rare disease drug that launched at the beginning of 2017, called Spinraza, that achieved a $1.5 billion annualized run rate during its fifth quarter since earning an FDA approval.

  • [By Keith Speights]

    Alnylam’s partner, Sanofi (NYSE:SNY), is taking the lead on a phase 3 study of another experimental RNAi therapeutic, fitusiran, in treating hemophilia A and B. Sanofi now has global rights to the drug as a result of a restructuring of the two companies’ rare disease collaboration agreement signed in 2014. Alnylam stands to receive royalties between 15% and 30% of any future sales for fitusiran. 

Top 10 Medical Stocks To Invest In 2019: Williams-Sonoma Inc.(WSM)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    And with just a few smart plays in today’s classic stock picker’s market, you can pull in triple-digit gains with just a small investment.

    Three Stocks to Watch Today: TGT, LOW, NAVG
    Target Corp. (NYSE: TGT) leads a busy day of earnings reports. The retail giant reported adjusted earnings per share of $1.47, a figure that topped expectations by 7 cents. The company beat revenue expectations, reported stronger same-store sales, and hiked its full-year forecast. Shares of TGT jumped 6.4% before the bell. Home improvement retail might be cooling off as higher interest rates put a dent into new-home sales. This morning, shares of Lowe’s Companies Inc. (NYSE: LOW) dropped 0.7% after the company reported earnings. The firm reported adjusted earnings per share of $2.07, a figure that beat expectations by 5 cents. Despite topping revenue expectations, the firm reported weaker-than-expected same-store sales and slashed its full-year outlook. In deal news, shares of Navigators Group (Nasdaq: NAVG) popped nearly 9%. The firm agreed to be purchased by Hartford Financial Services Group Inc. (NYSE: HIG) for $2.1 billion in cash. Look for additional earnings reports from L Brands Inc. (NYSE: LB), Williams-Sonoma Inc. (NYSE: WSM), Photronics Inc. (Nasdaq: PLAB), and Analog Devices Inc. (Nasdaq: ADI).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Leo Sun]

    This move expands Walmart’s home furnishing business into the backyard of specialty home furnishing companies like Williams-Sonoma (NYSE:WSM), which also owns Pottery Barn and West Elm. It also widens Walmart’s moat against Amazon, which is aggressively expanding into private-label products like consumer goods, apparel, and mattresses.

  • [By Leo Sun]

    Shares of Williams-Sonoma (NYSE:WSM) recently rallied to a fresh 52-week high after the retailer’s second quarter numbers topped analyst estimates. 

  • [By Jim Crumly]

    Retail companies are making news with earnings reports this week. Today, Best Buy (NYSE:BBY) and Williams-Sonoma (NYSE:WSM) both announced strong sales gains.

  • [By Lisa Levin] Gainers
    Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares surged 115.8 percent to $4.3591. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity.
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) jumped 38.2 percent to $3.0251 after the company disclosed that it achieved robust viral clearance for its manufacturing process.
    Universal Corporation (NYSE: UVV) surged 26.7 percent to $61.40 after reporting fiscal Q4 results.
    Hudson Technologies Inc. (NASDAQ: HDSN) rose 18.9 percent to $2.58.
    Evolus, Inc. (NASDAQ: EOLS) shares gained 17.8 percent to $22.8009.
    The Cato Corporation (NYSE: CATO) shares gained 17.5 percent to $21.07 after the company posted better-than-expected first-quarter results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.9 percent to $3.3613.
    Destination Maternity Corporation (NASDAQ: DEST) shares gained 15.5 percent to $3.35 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan.
    AXT, Inc. (NASDAQ: AXTI) rose 15 percent to $7.65.
    nLIGHT, Inc. (NASDAQ: LASR) gained 14.5 percent to $34.27 following Q1 results.
    Achieve Life Sciences, Inc. (NASDAQ: ACHV) rose 14.3 percent to $11.4303.
    Bilibili Inc.. (NASDAQ: BILI) shares climbed 13.9 percent to $14.16 after announcing Q1 results.
    Babcock & Wilcox Enterprises, Inc. (NYSE: BW) gained 13.2 percent to $2.91 after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake.
    HUYA Inc. (NYSE: HUYA) gained 13.1
  • [By Lisa Levin]

    Breaking news

    Best Buy Co., Inc. (NYSE: BBY) reported better-than-expected earnings for its first quarter.
    Sanderson Farms, Inc. (NASDAQ: SAFM) reported weaker-than-expected results for its second quarter.
    Medtronic plc (NYSE: MDT) reported upbeat earnings for its fourth quarter on Thursday.
    Williams-Sonoma, Inc. (NYSE: WSM) reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.

Top 10 Medical Stocks To Invest In 2019: ServiceMaster Global Holdings, Inc.(SERV)

Advisors’ Opinion:

  • [By Rich Smith]

    ServiceMaster (NYSE:SERV) stock is up a good 15.1% as of 11:35 a.m. EST after the company reported earnings below estimates for fiscal fourth-quarter 2018 but surpassed expectations for revenue.

  • [By Stephan Byrd]

    ServiceMaster (NYSE:SERV) insider Timothy M. Haynes sold 55,363 shares of the stock in a transaction that occurred on Thursday, May 3rd. The shares were sold at an average price of $53.18, for a total transaction of $2,944,204.34. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

  • [By Shane Hupp]

    Servicemaster Global Holdings Inc (NYSE:SERV) hit a new 52-week high and low during trading on Thursday . The company traded as low as $59.70 and last traded at $59.03, with a volume of 15886 shares trading hands. The stock had previously closed at $59.62.

  • [By Max Byerly]

    ServiceMaster (NYSE:SERV)’s share price reached a new 52-week high and low during trading on Tuesday . The company traded as low as $55.63 and last traded at $54.76, with a volume of 207508 shares traded. The stock had previously closed at $55.35.

  • [By Logan Wallace]

    Xact Kapitalforvaltning AB raised its stake in Servicemaster Global Holdings Inc (NYSE:SERV) by 33.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,711 shares of the business services provider’s stock after acquiring an additional 3,900 shares during the period. Xact Kapitalforvaltning AB’s holdings in Servicemaster Global were worth $799,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top 10 Medical Stocks To Invest In 2019: Farmer Brothers Company(FARM)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Farmer Bros Co (NASDAQ:FARM) CEO Michael H. Keown sold 23,333 shares of the business’s stock in a transaction that occurred on Monday, September 10th. The shares were sold at an average price of $28.03, for a total transaction of $654,023.99. Following the completion of the transaction, the chief executive officer now directly owns 68,405 shares of the company’s stock, valued at approximately $1,917,392.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

  • [By Stephan Byrd]

    BidaskClub upgraded shares of Farmer Brothers (NASDAQ:FARM) from a strong sell rating to a sell rating in a research note released on Friday morning.

  • [By Joseph Griffin]

    Shares of Farmer Brothers (NASDAQ:FARM) reached a new 52-week high and low during mid-day trading on Tuesday . The stock traded as low as $23.60 and last traded at $24.15, with a volume of 728 shares changing hands. The stock had previously closed at $23.70.

  • [By Motley Fool Transcribing]

    Farmer Brothers (NASDAQ:FARM) Q4 2018 Earnings Conference CallSep. 11, 2018 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Lisa Levin] Gainers
    Loxo Oncology, Inc. (NASDAQ: LOXO) rose 17.1 percent to $163.30 in pre-market trading as the company disclosed that LOXO-292 Phase 1 trial abstract was selected for 'Best of ASCO'.
    CytomX Therapeutics, Inc. (NASDAQ: CTMX) rose 11.5 percent to $27.15 in pre-market trading after the company announced presentations at the 2018 ASCO Annual Meeting.
    Check-Cap Ltd. (NASDAQ: CHEK) rose 12.3 percent to $5.47 in pre-market trading after reporting narrower-than-expected Q1 loss.
    Flotek Industries, Inc. (NYSE: FTK) shares rose 7.1 percent to $3.62 in the pre-market trading session.
    Baozun Inc. (NASDAQ: BZUN) shares rose 5.8 percent to $47.65 in pre-market trading after reporting Q1 results.
    World Wrestling Entertainment, Inc. (NYSE: WWE) rose 5.5 percent to $46.00 in pre-market trading.
    Williams Partners L.P. (NYSE: WPZ) rose 5.3 percent to $40.50 in pre-market trading after The Williams Companies, Inc. (NYSE: WMB) announced agreement to acquire all public equity of Williams Partners in a $10.5 billion deal.
    Koss Corporation (NASDAQ: KOSS) shares rose 4.6 percent to $2.72 in pre-market trading after surging 12.55 percent on Wednesday.
    Enphase Energy, Inc. (NASDAQ: ENPH) rose 4.5 percent to $5.85 in pre-market trading after gaining 5.66 percent on Wednesday.
    Farmer Bros. Co. (NASDAQ: FARM) rose 4.1 percent to $27 in pre-market trading after climbing 7.90 percent on Wednesday.
    Kosmos Energy Ltd. (NYSE: KOS) rose 4 percent to $7.70 in pre-market trading.

     

  • [By Trey Thoelcke]

    If Coca-Cola intends to stay focused on coffee for the time being, perhaps Farmer Bros. Co. (NASDAQ: FARM) could be a potential target. This distributor of coffee and other beverage and food products sports a market cap near $500 million.

Top 10 Medical Stocks To Invest In 2019: PNC Financial Services Group, Inc. (PNC)

Advisors’ Opinion:

  • [By Max Byerly]

    Wesbanco Bank Inc. grew its position in shares of PNC Financial Services Group Inc (NYSE:PNC) by 12.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 80,250 shares of the financial services provider’s stock after buying an additional 8,777 shares during the quarter. Wesbanco Bank Inc.’s holdings in PNC Financial Services Group were worth $12,137,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Shah Gilani]

    It doesn’t matter that other banks like JPMorgan Chase & Co. (NYSE: JPM), Bank of America Corp. (NYSE: BAC), and The PNC Financial Services Group Inc. (NYSE: PNC) don’t force-place insurance on their auto loan customers.

  • [By Chris Lange]

    PNC Financial Services Group Inc. (NYSE: PNC) is set to report its third-quarter results before the opening bell on Friday. The analysts’ consensus estimates call for EPS of $2.73 and $4.35 billion in revenue. Shares were changing hands at $138.52 on Friday’s close. The consensus price target is $158.91, and the stock has a 52-week range of $130.46 to $163.59.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Friday was The PNC Financial Services Group, Inc. (NYSE: PNC) which traded down about 4% at $145.63. The stock’s 52-week range is $115.45 to $163.59. Volume was over 4 million compared to the daily average volume of 2.3 million.

  • [By Garrett Baldwin]

    Earnings season will kick into high gear today with the release of multiple reports from three of the nation’s top financial institutions. JPMorgan Chase & Co. (NYSE: JPM), Wells Fargo & Co. (NYSE: WFC), and Citigroup Inc. (NYSE: C) will all be in the spotlight today. U.S. President Donald Trump could be shaking up trade policy. However, it isn’t NAFTA or tariffs with China that are headlining the story. According to reports, Trump has requested his advisors explore American reentry into the Transpacific Partnership (TPP). President Trump pulled the United States out of TPP shortly following his inauguration. The recommendation comes after lawmakers from ag-producing states discussed the impact of leaving the deal with the administration. The decision to reenter the TPP would be very valuable to states that produce the bulk of U.S. wheat given that it would allow exporters to avoid tariffs of $65 per tonne to Japan, which is the largest export market for American wheat. Leading nations of the pact, such as Japan and Australia, reacted coolly to the president’s pivot but did not rule out the possibility of American reentry. Facebook Inc. (Nasdaq: FB) is still in focus across the financial world. Facebook CEO Mark Zuckerberg appeared before Congress two times this week to address his firm’s ongoing data scandal involving consulting firm Cambridge Analytica. Congress’ failure to understand how the Internet works and Facebook’s business model was on full display, but Zuckerberg was able to maintain his composure as he answered questions over the two-day period.
    Stocks to Watch Today: JPM, WFC, C
    Shares of JPMorgan Chase & Co. (NYSE: JPM) are in focus as the bank prepares to report Q1 earnings before the bell. JPM stock added 1.1% despite falling short of profit expectations. Wall Street anticipated that the firm would report earnings per share (EPS) of $2.28 on top of $27.53 billion in revenue. The firm reported EPS of $2.26; however, it reported

Top 10 Medical Stocks To Invest In 2019: La-Z-Boy Incorporated(LZB)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    According to Money Morning Capital Wave Strategist Shah Gilani, we shouldn’t be surprised. Here’s what you need to know to stay out ahead of the next major crash.

    Three Stocks to Watch Today: ORCL, FDX, GME
    Oracle Corp. (NYSE: ORCL) will lead a slim roster of earnings reports on Tuesday. Wall Street anticipates that the cloud computing giant will report earnings per share (EPS) of $0.94 on top of $11.20 billion in revenue. FedEx Corp. (NYSE: FDX) will report earnings after the bell. Wall Street anticipates that the shipping giant will report EPS of $5.71 on top of $17.19 billion in revenue. But forget the earnings report. As we noted this week, a major standoff is about to push FDX stock through the roof. Learn more about this huge profit potential. Shares of GameStop Corp. (NYSE: GME) will look to continue their momentum thanks to buyout interest. Multiple media outlets report that private equity companies are exploring potential deals that would take the video game retailer private in the near future. Shares of the Texas-based firm gained nearly 9% yesterday. According to Reuters, Sycamore Partners is one of the firms interested in a potential takeover. Look for an additional earnings report from La-Z-Boy Inc. (NYSE: LZB). The average analyst projection calls for EPS of $0.64 on top of $426.75 million in revenue.

    Follow Money Morning on Twitter, Facebook, and LinkedIn.

  • [By Steve Symington]

    Shares of La-Z-Boy Incorporated (NYSE:LZB) were up 12.6% as of 1:30 p.m. EDT on Wednesday after the furniture producer announced strong fiscal first-quarter 2019 results.

  • [By Garrett Baldwin]

    If the answer is no, then understand that you are not alone – and you need to click here now…

    Stocks to Watch Today: HSBC, NAVI, LUV
    Shares of HSBC Holdings Plc. (NYSE: HSBC) fell more than 2% in pre-market hours. The slide came after the bank announced that it anticipated “a weaker global economic outlook.” The bank also issued a warning about the upcoming Brexit and said that many of its customers in the United Kingdom are “understandably cautious about the immediate future.” The firm also issued a weaker earnings report than expected. The company to watch today is Navient Corp. (NASDAQ: NAVI), which is the largest student loan servicer in the country. Sallie Mae spun off the company in 2013. It has 12 million customers and services about $300 billion in loans. While no one likes student loans, a few key metrics show this stock is a raging buy right now. Here’s what you need to know to get your trading week started. Southwest Airlines Co. (NYSE: LUV) is under scrutiny from the Federal Aviation Administration. According to reports, a probe is underway on whether the company has failed to calculate checked baggage loads on flights correctly. The Wall Street Journal reports that several planes carried 1,000 pounds of cargo more than what was listed on flight paperwork. Look for earnings reports from Advance Auto Parts Inc. (NYSE: AAP), Ecolab Inc. (NYSE: ECL), La-Z-Boy Inc. (NYSE: LZB), LendingClub Corp. (NYSE: LC), and Texas Roadhouse Inc. (NASDAQ: TXRH).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

Top 10 Medical Stocks To Invest In 2019: Dupont Fabros Technology, Inc.(DFT)

Advisors’ Opinion:

  • [By Shane Hupp]

    DigiFinexToken (CURRENCY:DFT) traded 0.6% lower against the U.S. dollar during the twenty-four hour period ending at 19:00 PM Eastern on March 8th. One DigiFinexToken token can currently be purchased for about $0.17 or 0.00004327 BTC on exchanges. During the last week, DigiFinexToken has traded 12.7% higher against the U.S. dollar. DigiFinexToken has a total market capitalization of $0.00 and $984,872.00 worth of DigiFinexToken was traded on exchanges in the last 24 hours.

  • [By Logan Wallace]

    DigiFinexToken (CURRENCY:DFT) traded down 9.8% against the dollar during the 1-day period ending at 0:00 AM Eastern on September 19th. One DigiFinexToken token can now be purchased for about $0.20 or 0.00003197 BTC on cryptocurrency exchanges. During the last seven days, DigiFinexToken has traded 30.7% lower against the dollar. DigiFinexToken has a market cap of $0.00 and $858,232.00 worth of DigiFinexToken was traded on exchanges in the last day.

  • [By Shane Hupp]

    DraftCoin (CURRENCY:DFT) traded up 4.5% against the US dollar during the 24-hour period ending at 20:00 PM E.T. on September 1st. DraftCoin has a total market capitalization of $623,381.00 and approximately $26,777.00 worth of DraftCoin was traded on exchanges in the last day. One DraftCoin coin can now be bought for $0.0779 or 0.00001084 BTC on major cryptocurrency exchanges including CoinExchange and YoBit. Over the last week, DraftCoin has traded 3.1% lower against the US dollar.

  • [By Shane Hupp]

    DraftCoin (CURRENCY:DFT) traded 1.5% lower against the U.S. dollar during the 1 day period ending at 9:00 AM Eastern on October 9th. During the last seven days, DraftCoin has traded 0.7% lower against the U.S. dollar. DraftCoin has a total market cap of $185,310.00 and approximately $3,088.00 worth of DraftCoin was traded on exchanges in the last 24 hours. One DraftCoin coin can now be bought for about $0.0231 or 0.00000351 BTC on exchanges including CoinExchange, YoBit and Coindeal.

Top 10 Medical Stocks To Invest In 2019: B2Gold Corp(BTG)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on B2Gold (BTG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    CIBC World Markets Inc. reduced its holdings in B2Gold Corp. (NYSEAMERICAN:BTG) (TSE:BTO) by 10.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 572,525 shares of the basic materials company’s stock after selling 64,714 shares during the period. CIBC World Markets Inc. owned approximately 0.06% of B2Gold worth $1,563,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    A number of research firms have changed their ratings and price targets for BTG (LON: BTG):

    9/7/2018 – BTG had its “buy” rating reaffirmed by analysts at Numis Securities Ltd. 9/7/2018 – BTG had its “buy” rating reaffirmed by analysts at Shore Capital. 9/4/2018 – BTG had its “hold” rating reaffirmed by analysts at Peel Hunt. 9/4/2018 – BTG had its “hold” rating reaffirmed by analysts at Deutsche Bank AG. They now have a GBX 645 ($8.40) price target on the stock. 8/21/2018 – BTG had its “neutral” rating reaffirmed by analysts at JPMorgan Chase & Co.. They now have a GBX 650 ($8.47) price target on the stock. 8/9/2018 – BTG had its “hold” rating reaffirmed by analysts at Peel Hunt. They now have a GBX 640 ($8.34) price target on the stock. 8/9/2018 – BTG had its “buy” rating reaffirmed by analysts at Shore Capital. 8/1/2018 – BTG had its “hold” rating reaffirmed by analysts at Peel Hunt. 7/19/2018 – BTG had its “hold” rating reaffirmed by analysts at Deutsche Bank AG.

    Shares of BTG stock opened at GBX 558.50 ($7.27) on Monday. BTG plc has a one year low of GBX 559.82 ($7.29) and a one year high of GBX 784 ($10.21).

  • [By Stephan Byrd]

    B2Gold Corp. (TSE:BTO) (NYSE:BTG) – Research analysts at National Bank Financial issued their Q3 2018 earnings per share estimates for shares of B2Gold in a report released on Wednesday, August 15th. National Bank Financial analyst D. Demarco anticipates that the company will post earnings per share of $0.05 for the quarter. National Bank Financial currently has a “Outperform” rating and a $6.50 target price on the stock. National Bank Financial also issued estimates for B2Gold’s FY2020 earnings at $0.30 EPS.

Top 10 Medical Stocks To Invest In 2019: Bank of the Ozarks(OZRK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    The Manufacturers Life Insurance Company lessened its stake in shares of Bank Of The Ozarks Inc (NASDAQ:OZRK) by 3.2% in the first quarter, HoldingsChannel.com reports. The firm owned 196,473 shares of the financial services provider’s stock after selling 6,499 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Bank Of The Ozarks were worth $9,484,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Bank Of The Ozarks (OZRK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephen Mack]

    Bank of the Ozarks Inc. (Nasdaq: OZRK) began in 1903 with a community bank in Jasper, Ark. Now headquartered in Little Rock, the company operates more than 255 locations in the southeast, as well as in California, Texas, and New York.

  • [By Motley Fool Staff]

    Bank of the Ozarks (NASDAQ: OZRK)Q2 2018 Bank Of The Ozarks Earnings CallJul. 12, 2018, 3:00 pm ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Medical Stocks To Invest In 2019: Dr. Reddy’s Laboratories Ltd(RDY)

Advisors’ Opinion:

  • [By Keith Speights]

    The third reason behind Celgene’s low valuation is a potential threat to the biotech’s top drug Revlimid. Celgene is fighting a patent challenge over Revlimid from Dr. Reddy’s Laboratories (NYSE:RDY). The hematology drug currently generates 63% of Celgene’s total revenue. 

  • [By Shane Hupp]

    Dr.Reddy’s Laboratories (NYSE:RDY) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

    Regenxbio (NASDAQ:RGNX) was upgraded by analysts at ValuEngine from a buy rating to a strong-buy rating.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Advance Auto Parts, Inc. (NYSE: AAP) is projected to report quarterly earnings at $1.97 per share on revenue of $2.91 billion.
    Kohl's Corporation (NYSE: KSS) is expected to report quarterly earnings at $0.5 per share on revenue of $3.95 billion.
    The TJX Companies, Inc. (NYSE: TJX) is projected to report quarterly earnings at $1.02 per share on revenue of $8.47 billion.
    AutoZone, Inc. (NYSE: AZO) is estimated to report quarterly earnings at $13.01 per share on revenue of $2.72 billion.
    Dycom Industries, Inc. (NYSE: DY) is projected to report quarterly earnings at $0.7 per share on revenue of $734.86 million.
    Eaton Vance Corp. (NYSE: EV) is estimated to report quarterly earnings at $0.79 per share on revenue of $425.42 million.
    Photronics, Inc. (NASDAQ: PLAB) is expected to report quarterly earnings at $0.07 per share on revenue of $124.17 million.
    Cracker Barrel Old Country Store, Inc. (NASDAQ: CBRL) is estimated to report quarterly earnings at $1.93 per share on revenue of $715.15 million.
    Radcom Ltd. (NASDAQ: RDCM) is expected to post quarterly earnings at $1.96 per share on revenue of $718.59 million.
    Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) is projected to report quarterly earnings at $0.04 per share on revenue of $718.96 million.
    CYREN Ltd. (NASDAQ: CYRN) is estimated to report quarterly loss at $0.08 per share on revenue of $7.72 million.
    Ferroglobe PLC (NYSE: GSM) is projected to report quarterly earnings at $0.16 per share on revenue of $559.15 million.
    Dr. Reddy's Laboratories Limited (NYSE: RDY) is estimated to report earnings for its fourth quarter.
    BioLineRx Ltd. (NASDAQ: BLRX) is expected to report quarterly loss at $0.07 per share.
    Toll Brothers, Inc. (NYSE: TOL) is estimated to post quarterly earnings at $0.76 per share on revenue of $1.58 billion.

     

  • [By Keith Speights]

    Investors’ biggest worry about Celgene is that it might not have as much time as hoped to replace the revenue that Revlimid generates: Dr. Reddy’s Laboratories (NYSE:RDY) is challenging Celgene’s patents for Revlimid.

Top Tech Stocks To Own For 2019

The digital payments industry is gargantuan, and it’s only getting bigger from here.

In this clip from Industry Focus: Technology, analyst Dylan Lewis and Motley Fool contributor Matthew Cochrane examine payments behemoth PayPal (NASDAQ:PYPL) and its many different segments, and discuss which areas investors should keep an eye on. Watch to find out more about PayPal’s central platform, as well as Braintree, Venmo, and the ultra-sticky One Touch.

A full transcript follows the video.

This video was recorded on May 25, 2018.

Dylan Lewis: Why don’t we do a quick couple of minutes on the story with PayPal, how things have looked over the last couple years, and what investors are watching?

Matthew Cochrane: Sure. I think, most people are semi-familiar with PayPal. It’s the world’s largest open digital payment platform, which consumers can use to move and manage their money. Every time consumers use PayPal to make a transaction, PayPal takes just a little off the top. We’re talking about a fraction of a percentage point, but it quickly adds up, when you’re talking about billions of transactions.

Top Tech Stocks To Own For 2019: Edge Therapeutics, Inc.(EDGE)

Advisors’ Opinion:

  • [By Paul Ausick]

    Edge Therapeutics Inc. (NASDAQ: EDGE) dropped 14.5% Thursday to post a new 52-week low of $1.12. Shares closed at $1.31 on Wednesday and the stock’s 52-week high is $17.77. Volume was nearly 20 times the daily average of around 700,000 shares. The company on Wednesday ended a trial after reporting poor results and shares fell more than 90% on the news.

  • [By Paul Ausick]

    Edge Therapeutics Inc. (NASDAQ: EDGE) dropped 92.6% Wednesday to post a new 52-week low of $1.15. Shares closed at $15.59 on Tuesday and the stock’s 52-week high is $17.77. Volume was nearly 300 times the daily average of around 160,000 shares. The company ended a trial after reporting poor results.

  • [By Logan Wallace]

    Media headlines about Edge Therapeutics (NASDAQ:EDGE) have been trending somewhat positive on Sunday, according to Accern. Accern rates the sentiment of news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Edge Therapeutics earned a media sentiment score of 0.02 on Accern’s scale. Accern also assigned media headlines about the biotechnology company an impact score of 42.6657723226264 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Logan Wallace]

    Edge Therapeutics (NASDAQ:EDGE) was upgraded by equities researchers at ValuEngine from a “sell” rating to a “hold” rating in a note issued to investors on Wednesday.

  • [By Ethan Ryder]

    Edge Therapeutics Inc (NASDAQ:EDGE) shares were down 6.8% on Tuesday . The stock traded as low as $1.07 and last traded at $1.10. Approximately 1,087,000 shares changed hands during mid-day trading, a decline of 7% from the average daily volume of 1,164,140 shares. The stock had previously closed at $1.18.

Top Tech Stocks To Own For 2019: Petroleum Resources Corporation(PEO)

Advisors’ Opinion:

  • [By Shane Hupp]

    Press coverage about Adams Natural Resources Fund (NYSE:PEO) has trended somewhat negative recently, Accern reports. The research group identifies positive and negative news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Adams Natural Resources Fund earned a coverage optimism score of -0.09 on Accern’s scale. Accern also assigned news articles about the financial services provider an impact score of 48.0521373671292 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Top Tech Stocks To Own For 2019: B2Gold Corp(BTG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Deutsche Bank reiterated their hold rating on shares of BTG (LON:BTG) in a report released on Tuesday morning. Deutsche Bank currently has a GBX 645 ($8.32) price target on the stock.

  • [By Max Byerly]

    Here’s how other cryptocurrencies have performed during the last day:

    Get Bitgem alerts:

    Zcash (ZEC) traded 7.4% lower against the dollar and now trades at $243.26 or 0.03355620 BTC. Bitcoin Gold (BTG) traded 6% lower against the dollar and now trades at $41.47 or 0.00572057 BTC. Bitcoin Private (BTCP) traded up 1.3% against the dollar and now trades at $22.93 or 0.00316296 BTC. ZenCash (ZEN) traded 7.9% lower against the dollar and now trades at $29.94 or 0.00412942 BTC. ZClassic (ZCL) traded down 2.8% against the dollar and now trades at $11.31 or 0.00155982 BTC. BitcoinZ (BTCZ) traded 0.5% lower against the dollar and now trades at $0.0019 or 0.00000026 BTC. Hush (HUSH) traded 0.7% lower against the dollar and now trades at $0.83 or 0.00011450 BTC. Zero (ZER) traded up 13% against the dollar and now trades at $0.58 or 0.00008000 BTC. VoteCoin (VOT) traded 3.3% lower against the dollar and now trades at $0.0127 or 0.00000175 BTC. Bitcoin Interest (BCI) traded up 0.2% against the dollar and now trades at $4.83 or 0.00066692 BTC.

    Bitgem Profile

  • [By Max Byerly]

    Get a free copy of the Zacks research report on B2Gold (BTG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Deutsche Bank reaffirmed their hold rating on shares of BTG (LON:BTG) in a report released on Wednesday.

    A number of other equities research analysts have also weighed in on BTG. Shore Capital upgraded BTG to a buy rating in a research report on Monday, March 26th. Peel Hunt restated a hold rating and set a GBX 700 ($9.32) price objective on shares of BTG in a research report on Wednesday, April 4th. JPMorgan Chase & Co. reduced their price objective on BTG from GBX 750 ($9.99) to GBX 680 ($9.05) and set a neutral rating on the stock in a research report on Friday, April 6th. Jefferies Financial Group boosted their price objective on BTG from GBX 775 ($10.32) to GBX 900 ($11.98) and gave the stock a buy rating in a research report on Tuesday, May 15th. Finally, Numis Securities reiterated a buy rating and issued a GBX 840 ($11.18) price target on shares of BTG in a research report on Tuesday, May 15th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock has a consensus rating of Buy and an average price target of GBX 745.83 ($9.93).

  • [By Stephan Byrd]

    B2Gold (TSE:BTO) (NYSE:BTG) had its price objective trimmed by Pi Financial from C$5.25 to C$5.10 in a research report released on Friday.

    A number of other research firms have also recently weighed in on BTO. Canaccord Genuity lowered their target price on shares of B2Gold from C$7.00 to C$6.50 in a research note on Tuesday, July 24th. National Bank Financial lowered their target price on shares of B2Gold from C$7.00 to C$6.50 and set an outperform rating on the stock in a research note on Saturday, July 14th. Scotiabank reissued an outperform rating and issued a C$5.00 target price on shares of B2Gold in a research note on Monday, May 28th. Finally, Royal Bank of Canada lowered their target price on shares of B2Gold from C$5.00 to C$4.50 and set an outperform rating on the stock in a research note on Tuesday, May 22nd. Six investment analysts have rated the stock with a buy rating, B2Gold presently has a consensus rating of Buy and an average target price of C$5.38.

Top 10 Heal Care Stocks To Buy Right Now

Wednesday November 15: Five things the markets are talking about

Market risk-off continues to dominate capital market moves; both European and Asian stocks have seen ‘red' in their sessions while bonds and gold prices advanced.

The dollar had fallen to its lowest level in nearly three weeks overnight, reflecting the diminishing expectations that Republicans will be able to push through a tax overhaul this year.

Investors attention now turns to data coming out of the U.S this morning – consumer prices and retail sales (08:30 am EDT) should provide clues on the strength of the world's largest economy after the ‘flattest' U.S Treasury yield curve in a decade is raising concern that growth will slow.

1. Stocks see ‘red'

In Japan, the Nikkei share average fell to a new two-week low overnight, with all sectors in negative territory as investors took profits following a two-month rally that pushed the index up by about +20%. The index ended down -1.6%, while the broader Topix closed -2% to seal its longest streak of losses since September 2016.

Top 10 Heal Care Stocks To Buy Right Now: Unilever NV(UN)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, industrial shares fell by 0.04 percent. Meanwhile, top losers in the sector included Unilever N.V. (ADR) (NYSE: UN), down 8 percent, and Magal Security Systems Ltd. (USA) (NASDAQ: MAGS), down 6 percent.

  • [By Teresa Rivas]

    Earlier this year, Unilever (UN) recently declined Kraft Heinz (KHC) merger bid. That means that if the company still wants to do a deal, Mondelez International (MDLZ) and PepsiCo (PEP) are the next logical partners, writes Susquehannas Pablo Zuanic.

    Getty Images

    Zuanic upgraded Pepsi from Neutral to Positive today and raised his price target from $118 to $132. He writes that a Pepsi deal would have more strategic merits, hence his upgrade (as he emphasizes that not much has changed in terms of fundamentals for the firm).

    More detail from his note:

    With investors apparently seeing MDLZ as the next likely KHC target, and Coca-Cola (KO) the next Anheuser-Busch (BUD) target, PEP shares have lost visibility and now trade at a 25% discount to KO on apples-to-apples comps. We see value here, on franchise strength, efforts to align the F&B portfolio with consumer health trends, and the growing optionality value of a joint KHC/BUD bid for PEP. We argue that, together, the Kendall Jenner commercial, the Aspartame to-be-or-not-to-be zigzagging, the new, new, new alt low-cal cola (Pepsi Zero sugar), the ongoing underperformance in U.S. CSDs (25% only of the company), the lack of scale in non-CSD NARTDs vs. KO (other than Gatorade), and now talk of PEP buying Brazilian dairy company Vigor S.A. (a JBS subsidiary that would better fit KHC or ULVR), all paint a picture of a company still struggling to set a new direction (with all due respect). In this regard, we think PEP may be more vulnerable than MDLZ to a KHC bid (jointly done with BUD). We also see greater strategic fit for KHC with PEP Food/Snacks (than with MDLZ), and argue that PEP Beverages fits BUD better than KO, as the PEP bottling operations in key regions (including NA) remain in the hands of PEP (KO, on the other hand will be fully refranchised by end of 2017). So we are upgrading PEP to Positive with a $132 price target by December 17. Yes, the Unilever rebuff

Top 10 Heal Care Stocks To Buy Right Now: Advantage Lithium Corp. (AVLIF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].

Top 10 Heal Care Stocks To Buy Right Now: Addus HomeCare Corporation(ADUS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Marathon Patent Group Inc (NASDAQ: MARA) shares rose 47.1 percent to $3.22 in pre-market trading after jumping 54.23 percent on Wednesday.
    Digital Power Corporation (NYSE: DPW) rose 27.6 percent to $0.800 in pre-market trading after gaining 9.79 percent on Wednesday.
    Social Reality Inc (NASDAQ: SRAX) shares rose 23.1 percent to $7.16 in the pre-market trading session after surging 37.59 percent on Wednesday.
    China Auto Logistics Inc (NASDAQ: CALA) rose 16.9 percent to $4.15 in pre-market trading after gaining 4.11 percent on Wednesday.
    Riot Blockchain Inc (NASDAQ: RIOT) rose 15.1 percent to $18.40 in pre-market trading after climbing 42.01 percent on Wednesday.
    Seven Stars Cloud Group Inc (NASDAQ: SSC) rose 14.5 percent to $2.85 in the pre-market trading session after gaining 0.40 percent on Wednesday.
    Affimed NV (NASDAQ: AFMD) shares rose 14.3 percent to $2.40 in pre-market trading after gaining 4.88 percent on Wednesday.
    Corecivic Inc (NYSE: CXW) rose 10.2 percent to $25.56 in pre-market trading after climbing 0.65 percent on Wednesday.
    LM Funding America, Inc. (NASDAQ: LMFA) rose 9.6 percent to $3.30 in pre-market trading after surging 34.98 percent on Wednesday.
    U.S. Global Investors, Inc. (NASDAQ: GROW) rose 7.2 percent to $3.30 in pre-market trading after dropping 8.06 percent on Wednesday.
    Xunlei Ltd (NASDAQ: XNET) rose 6.8 percent to $25.61 in pre-market trading after climbing 11.74 percent on Wednesday.
    Net 1 UEPS Technologies Inc (NASDAQ: UEPS) shares rose 5.9 percent to $13.00 in pre-market trading after gaining 21.34 percent on Wednesday.
    Addus Homecare Corporation (NASDAQ: ADUS) rose 5.5 percent to $35.60 in pre-market trading after gaining 3.69 percent on Wednesday.
    TOP SHIPS Inc (NASDAQ: TOPS) rose 5.2 percent to $0.528 in pre-market trading after falling 10.36 percent on Wednesday.
    Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) rose 4.7 percent to $14.11 in pre-market trading. Teva Pharma

Top 10 Heal Care Stocks To Buy Right Now: Ethan Allen Interiors Inc.(ETH)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Wednesday was a strong day for the stock market, as the Dow finished up nearly 100 points and the S&P 500 and Nasdaq both posted gains as well. Investors remained generally upbeat about the prospects for the U.S. economy in 2017, and a rise in crude oil prices helped lift the energy sector higher during the market session. Yet comments during a press conference from President-elect Donald Trump weighed on the healthcare sector, and some individual stocks took particularly hard hits. Among the worst performers were Perrigo (NYSE:PRGO), Novadaq Technologies (NASDAQ:NVDQ), and Ethan Allen Interiors (NYSE:ETH). Below, we’ll look more closely at these stocks to tell you why they did so poorly.

Top 10 Heal Care Stocks To Buy Right Now: Sorrento Therapeutics, Inc.(SRNE)

Advisors’ Opinion:

  • [By William Romov]

    San Diego-based Sorrento Therapeutics Inc. (Nasdaq: SRNE) develops drugs to treat certain types of cancer and chronic cancer pain.

    On Jan. 6, company officials will present a new proprietary technology for the treatment of cancer. Analysts are calling this new technology a potential “game-changer.”

Top 10 Heal Care Stocks To Buy Right Now: B2Gold Corp(BTG)

Advisors’ Opinion:

  • [By Peter Graham]

    The following mining companies are active in Burkina Faso:

    Semafo Inc (TSE: SMF; OTCMKTS: SEMFF).SEMAFO operates the Mana Mine in Burkina Faso, which includes the high-grade satellite deposit of Siou, and is targeting production start-up of the Boungou Mine in the second half of 2018. SEMAFO’s strategic focus is to maximize shareholder value by effectively managing its existing assets as well as pursuing organic and strategic growth opportunities. SEMAFOs Mana Mine is located 260 kilometers southwest of the capital Ouagadougou. The third-largest mine in the country, it has produced some 1.6 million ounces since its first gold pour in 2008. Since then,the Company hasexpanded the plant four times to a current processing rate of over 7,200 tonnes per day. IAMGOLD Corp (NYSE: IAG). Iamgold has four operating gold mines on three continents with asolid base of strategic assets in North and South America and West Africa that is complemented by development and exploration projects with continued assessment of accretive acquisition opportunities. Iamgold is said to be thelargest private employer in Burkina Faso andhas a high level of exposure in the region with two operating mines in Mali and a mine in northern Burkina Faso near the Mali border. Roxgold Inc (TSE: ROXG; OTCMKTS: ROGFF). Roxgold is a gold mining company with its key asset, the high grade Yaramoko Gold Mine, located in the Hound茅 greenstone region of Burkina Faso, West Africa. The Company declared commercial production on October 1, 2016. The Yaramoko permit covers approximately 196km2 in the Province of Bal茅 in southwestern Burkina Faso. The property is located approximately 200 kilometres southwest from the capital city of Ouagadougou. Yaramoko lies directly south of, and is contiguous to, the SEMAFO Inc property hosting its flagship Mana Gold Mine and lies within the Hounde greenstone belt. Endeavour Mining Corp (TSE: EDV; OTCMKTS: EDVMF). Endeavour is ideally positioned as the majo

  • [By Lisa Levin] Related CXW Trump Or Clinton: Who Would Create More Jobs? The 2016 Economics Nobel Prize Winner's Case Against Private Prisons: Contracts Are The Key Wall Street Breakfast: Trump Takes The White House (Seeking Alpha)
    Related SAEX 20 Biggest Mid-Day Losers For Friday 22 Stocks Moving In Friday's Pre-Market Session SAExploration wins $35M seismic data deal (Seeking Alpha)
    Gainers
    Corrections Corp Of America (NYSE: CXW) shares rose 16.3 percent to $16.50 in pre-market trading following Donald Trump's victory.
    SAExploration Holdings, Inc. (NASDAQ: SAEX) shares rose 15.4 percent to $7.26 in pre-market trading after the company reported a new $35 million deep water ocean-bottom marine project award.
    The GEO Group Inc (NYSE: GEO) shares rose 12.9 percent to $26.95 in pre-market trading following Donald Trump's victory.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 12.3 percent to $7.40 in pre-market trading after gaining 0.30 percent on Tuesday.
    Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) rose 11.7 percent to $10.35 in pre-market trading. Ariad Pharmaceuticals disclosed that its Phase 1/2 trial data on investigational drug brigatinib were published in The Lancet Oncology.
    AK Steel Holding Corporation (NYSE: AKS) rose 11.2 percent to $6.75 in pre-market trading after gaining 3.23 percent on Tuesday.
    Pretium Resources Inc (NYSE: PVG) rose 11 percent to $10.50 in pre-market trading after declining 1.66 percent on Tuesday.
    First Majestic Silver Corp (NYSE: AG) rose 9.3 percent to $8.90 in the pre-market trading session. First Majestic reported Q3 earnings of $0.07 per share on revenue of $79.3 million. Silver futures gained 2.2 percent to $18.77 an ounce.
    Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) rose 9.2 percent to
  • [By Monica Gerson]

    B2Gold Corp (NYSE: BTG) is estimated to post its quarterly earnings at $0.00 per share on revenue of $135.84 million.

    Astro-Med, Inc. (NASDAQ: ALOT) is projected to post its quarterly earnings at $0.21 per share on revenue of $25.50 million.

Top 10 Heal Care Stocks To Buy Right Now: Enbridge Inc(ENB)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Not to be outdone, rival Canadian oil pipeline giant Enbridge (NYSE:ENB) announced a transformational gas-focused deal of its own, agreeing to acquire U.S. pipeline company Spectra Energy (NYSE:SE) for $28 billion. That transaction will catapult Enbridge past TransCanada and create the largest energy infrastructure company in North America. Further, the deal will bolster Enbridge’s near-term capital project backlog to $20 billion, while enhancing its inventory of longer-term investment opportunities to $37 billion. This pipeline supports Enbridge’s view that it can increase its dividend by 10% to 12% annually through 2024.

  • [By Jim Robertson]

    On Friday, our Under the Radar Moversnewsletter suggested shorting small cap energy transportation and distribution stock Enbridge Inc (NYSE: ENB):

Top 10 Heal Care Stocks To Buy Right Now: Ring Energy, Inc.(REI)

Advisors’ Opinion:

  • [By Monica Gerson]

    Ring Energy Inc (NYSE: REI) is projected to post a quarterly loss at $0.05 per share on revenue of $7.92 million.

    Gain Capital Holdings Inc (NYSE: GCAP) is estimated to post its quarterly earnings at $0.07 per share on revenue of $100.39 million.

Top 10 Heal Care Stocks To Buy Right Now: Tronox Limited(TROX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Tronox Ltd (NYSE: TROX) were down 23 percent to $19.55. The FTC has challenged Tronox acquisition of Cristal’s titanium dioxide business. Tronox disclosed that it will fight FTC lawsuit seeking to block proposed acquisition of Saudi-owned Cristal.

  • [By Lisa Levin]

    Tronox Ltd (NYSE: TROX) shares shot up 34 percent to $19.30. Tronox announced plans to acquire Cristal's TiO(2) business and also agreed to sell Alkali Business. Tronox posted a Q4 loss of $0.14 per share on revenue of $548 million.

Top 10 Heal Care Stocks To Buy Right Now: PHI, Inc.(PHIIK)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggested shorting small cap offshore oil and gas services stock PHI Inc (NASDAQ: PHIIK):

    We’re a little bit late to the party here, but that’s ok – there’s still some meat left on the bone, so to speak. Were looking for the stock to continue on to the lower edge of a long-term (and bearish) trading range that should allow it to peel back to at least the lower $12’s. We’ve see PHIIK shares tumble with great speed and distance a couple of times already, and we’re about halfway through round three.